Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Ac, Voordouw"'
Autor:
LT Vlasveld, A Hekman, FA Vyth-Dreese, EM Rankin, JGM Scharenberg, AC Voordouw, JJ Sein, TAM Dellemijn, S Rodenhuis, CJM Melief
Publikováno v:
British Journal of Cancer. 68:559-567
Autor:
Wm, Kast, Ja, Bluestone, Mh, Heemskerk, Joke Spaargaren, Ac, Voordouw, Jd, Ellenhorn, Cj, Melief
Publikováno v:
Europe PubMed Central
C57BL/6 mice are protected from a lethal pneumonia caused by Sendai virus when treated with low doses of mAb directed to the CD3 Ag. The protective mechanism is not due to an accelerated Sendai virus-specific Th cell, CTL, or antibody response but to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::04488171c0c271968fdec5decd9ba420
http://europepmc.org/abstract/med/2168920
http://europepmc.org/abstract/med/2168920
Autor:
Tg, Rossum, He, Melker, Houweling H, Ac, Voordouw, Cj, Meijer, Tj, Helmerhorst, Mirjam Kretzschmar, Berkhof J, van der Noordaa J
Publikováno v:
Europe PubMed Central
CIÊNCIAVITAE
CIÊNCIAVITAE
Each year, 600-700 women in the Netherlands are diagnosed with cervical cancer. Over the last 10 years, an average of 250 women have died annually due to cervical cancer. --Gardasil, the first vaccine for Human papillomavirus (HPV), was recently appr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::cf75ee6a34aac75dd7a7238b3996c32d
http://europepmc.org/abstract/med/18549172
http://europepmc.org/abstract/med/18549172
Autor:
Granström M; Department of Microbiology, Tumor- and Cellbiology, Karolinska Institutet and Clinical Microbiology, Karolinska University Hospital Solna, Stockholm, Sweden. marta.granstrom@ki.se, Voordouw AC
Publikováno v:
Vaccine [Vaccine] 2011 Oct 06; Vol. 29 (43), pp. 7572-5. Date of Electronic Publication: 2011 Aug 04.
Autor:
Voordouw AC; Pharmaco-epidemiology Unit, Departments of Internal Medicine and Epidemiology & Biostatistics, Erasmus University Medical Center, Rotterdam, The Netherlands. ac.voordouw@cbg-meb.nl, Beyer WE, Smith DJ, Sturkenboom MC, Stricker BH
Publikováno v:
Vaccine [Vaccine] 2009 Dec 11; Vol. 28 (2), pp. 392-7. Date of Electronic Publication: 2009 Oct 28.
Autor:
van Rossum TG; College ter Beoordeling van Geneesmiddelen, Den Haag. tg.v.rossum@cbg-meb.nl, de Melker HE, Houweling H, Voordouw AC, Meijer CJ, Helmerhorst TJ, Kretzschmar M, Berkhof J, van der Noordaa J
Publikováno v:
Nederlands tijdschrift voor geneeskunde [Ned Tijdschr Geneeskd] 2008 Apr 26; Vol. 152 (17), pp. 987-92.
Autor:
Voordouw AC; Pharmaco-epidemiology Unit, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands., Sturkenboom MC, Dieleman JP, Stijnen T, Smith DJ, van der Lei J, Stricker BH
Publikováno v:
JAMA [JAMA] 2004 Nov 03; Vol. 292 (17), pp. 2089-95.
Autor:
van Loon FP; College ter beoordeling van geneesmiddelen, Den Haag. fp.v.loon@cbg-meb.nl, Voordouw AC, Simonian S, Koopmans PP
Publikováno v:
Nederlands tijdschrift voor geneeskunde [Ned Tijdschr Geneeskd] 2000 Jan 22; Vol. 144 (4), pp. 165-7.
Autor:
Schinkel AH; Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam., Mayer U, Wagenaar E, Mol CA, van Deemter L, Smit JJ, van der Valk MA, Voordouw AC, Spits H, van Tellingen O, Zijlmans JM, Fibbe WE, Borst P
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 1997 Apr 15; Vol. 94 (8), pp. 4028-33.
Autor:
Vlasveld LT; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam., Hekman A, Vyth-Dreese FA, Melief CJ, Sein JJ, Voordouw AC, Dellemijn TA, Rankin EM
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 1995 Jan; Vol. 40 (1), pp. 37-47.